Introduction Differentiated thyroid cancer (DTC) is the most common of endocrine cancers.
Many studies have focused on recurrence-free survival of DTC patients, however, few …

Background The most important part of the follow-up of differentiated thyroid carcinoma
(DTC) is the measurement of serum thyroglobulin (Tg). An increase of Tg levels indicates …

In the present study we investigated the role of radio-guided surgery with Iodine-131 (I-131)
in a group of 31 patients with differentiated thyroid cancer (DTC) and loco-regional recurrent …

Objective To assess the prognostic value of detectable thyroglobulin (Tg) after initial surgery
and radioactive iodine (131I) therapy by comparing patients with a negative post …

The aim of this study was to evaluate the efficacy of different radioactive iodine (I-131)
activities used for re-ablation, to compare various combinations of treatment activities, and to …

Abstract 131I treatment is an important management method for patients with differentiated
thyroid cancer (DTC). Unsuccessful 131I ablation drastically affects the prognosis of the …

Background: Preablative stimulated thyroglobulin (ps-Tg) is an important investigation in the
follow-up of patients with Differentiated thyroid cancer (DTC) after surgery. Levels of ps-Tg> …

Metastatic differentiated thyroid carcinoma (DTC) with positive 131 I scintigraphy, but
negative stimulated Tg (sTg) is relatively rare in clinical practice. The clinical characteristics …

By far, differentiated thyroid cancer (DTC) is the most common form of thyroid cancer (TC)
accounting for about 90% of all TC in most industrialized countries [1]. Incidence has …

Background: Radioactive iodine (RAI) is widely used in the management of differentiated
thyroid cancer (DTC). The impact of the time interval between total thyroidectomy (TT) and …